Edith Cowan University

Research Online
Research outputs 2022 to 2026
1-1-2022

Assessment and monitoring of Achilles tendinopathy in clinical
practice: A qualitative descriptive exploration of the barriers
clinicians face
Myles Calder Murphy
Edith Cowan University, m.murphy@ecu.edu.au

James Debenham
Caroline Bulsara
Paola Chivers
Edith Cowan University, p.chivers@ecu.edu.au

Ebonie Kendra Rio

See next page for additional authors

Follow this and additional works at: https://ro.ecu.edu.au/ecuworks2022-2026
Part of the Medicine and Health Sciences Commons
10.1136/bmjsem-2022-001355
Murphy, M. C., Debenham, J., Bulsara, C., Chivers, P., Rio, E. K., Docking, S., ... & Gibson, W. (2022). Assessment and
monitoring of Achilles tendinopathy in clinical practice: A qualitative descriptive exploration of the barriers
clinicians face. BMJ open sport & exercise medicine, 8(2), 1-11, e001355. https://doi.org/10.1136/
bmjsem-2022-001355
This Journal Article is posted at Research Online.
https://ro.ecu.edu.au/ecuworks2022-2026/1015

Authors
Myles Calder Murphy, James Debenham, Caroline Bulsara, Paola Chivers, Ebonie Kendra Rio, Sean
Docking, Mervyn Travers, and William Gibson

This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworks2022-2026/1015

Qualitative research

Assessment and monitoring of Achilles
tendinopathy in clinical practice: a
qualitative descriptive exploration of
the barriers clinicians face
Myles Calder Murphy  ,1,2 James Debenham,1 Caroline Bulsara,1
Paola Chivers,3,4 Ebonie Kendra Rio,5 Sean Docking  ,5,6 Mervyn Travers,1,7
William Gibson1
To cite: Murphy MC,
Debenham J, Bulsara C, et al.
Assessment and monitoring
of Achilles tendinopathy in
clinical practice: a qualitative
descriptive exploration of the
barriers clinicians face. BMJ
Open Sport & Exercise Medicine
2022;8:e001355. doi:10.1136/
bmjsem-2022-001355
► Additional supplemental
material is published online
only. To view, please visit the
journal online (http://dx.doi.
org/10.1136/bmjsem-2022-
001355).

Accepted 25 May 2022

© Author(s) (or their
employer(s)) 2022. Re-use
permitted under CC BY-NC. No
commercial re-use. See rights
and permissions. Published by
BMJ.

ABSTRACT
Our primary objective was to explore the barriers
preventing clinicians from implementing what they
think is ideal practice as it relates to using tools to aid
diagnosis and monitor progress in mid-portion Achilles
tendinopathy. Our secondary objectives were to describe
the assessments employed by clinicians in their own
practice to aid with (a) diagnosis and (b) monitoring
progress in Achilles tendinopathy and explore the outcome
measure domains clinicians believe to be the most and
least important when managing patients with Achilles
tendinopathy. We employed a qualitative descriptive study
design. Thirteen participants (eight female, five male) from
across Australia, consisting of two junior physiotherapists,
five senior physiotherapists working in private practice,
four senior physiotherapists working within elite sports
organisations and two sport and exercise medicine
doctors, were included and one-on-one interviews were
performed. Audio was transcribed then entered into NVivo
for coding and analysis. Four main themes were perceived
as barriers to implementing ideal practice of assessment
and monitoring in people with Achilles tendinopathy:
financial constraints, time constraints, access to equipment
and patient symptom severity. Assessments related to
function, pain on loading, pain over a specified time frame
and palpation are commonly used to assist diagnosis.
Assessments related to disability, pain on loading, pain
over a specified time frame and physical function capacity
are used to monitor progress over time. Furthermore, pain
on loading and pain over a specified time frame were
considered the most important outcome measure domains
for assisting diagnosis whereas pain on loading, patient
rating of the condition and physical function capacity
were the most important outcome measure domains
for monitoring progress. A number of barriers exist that
prevent clinicians from implementing what they view as
ideal assessment and monitoring for Achilles tendinopathy.
These barriers should be considered when developing new
assessments and in clinical practice recommendations.
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INTRODUCTION
Achilles tendinopathy is characterised by pain,
stiffness and a loss of function in both athletic

KEY MESSAGES
WHAT IS ALREADY KNOWN
⇒ Clinicians perform a number of different assess-

ments for tendinopathy, across a variety of different
outcome measure domains.
⇒ However, research quantifying what is current assessment and monitoring as well as the barriers in
clinical practice does not exist.

WHAT ARE THE NEW FINDINGS
⇒ Four main themes were perceived as barriers to im-

plementing ideal practice of assessment and monitoring in people with Achilles tendinopathy: financial
constraints, time constraints, access to equipment
and patient symptom severity.
⇒ Pain on loading and pain over a specified time frame
were considered the most important outcome measure domains for assisting diagnosis.
⇒ Pain on loading, patient rating of the condition and
physical function capacity were considered the most
important outcome measure domains for monitoring
progress.

and sedentary populations1 2 with exercise
rehabilitation recommended as best management for this condition.3–6 Various assessment
tools exist for mid-
portion Achilles tendinopathy and have been used for diagnosis,
as study inclusion criteria and as outcome
measures to monitor progress.5 7–11 Examples
include a patient’s self-
reported pain with
functional tasks, validated patient-
reported
outcome measures or an objective assessment
of functional capacity.12 13 However, not all
tools have been validated,14 thus it is valuable
to find out what is being used (and how) in
clinical practice regarding the assessment
and monitoring of Achilles tendinopathy.
There is little consistency between
published studies in the assessments used
to quantify demographic information, diagnose the condition or assess improvements
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in different systems (eg, tendon structure or muscle
force production) relevant to rehabilitation.12 13 15 For
instance, across exercise rehabilitation trials to treat mid-
portion Achilles tendinopathy, we identified numerous
assessment tools used to assess different aspects of pain
and function,12 13 yet few reported data related to their
reliability and validity.12 13 The lack of data on the identified assessment reliability is an issue as it undermines
any analysis to determine if change has truly occurred16
and likely makes the diagnosis and monitoring of mid-
portion Achilles tendinopathy even more challenging
for clinicians, because if research studies are not using
consistent assessments how can we expect that from clinicians?
In 2019, three international consensus statements
(ICON 2019) were developed by expert clinicians and
researchers with a special interest in tendons as well as
patients with tendinopathy, to consolidate our understanding of tendinopathy, including tendon terminology,17
reporting of participant characteristics18 and core health
domains.19 In the absence of ‘gold-standard’ diagnostic
criteria for tendinopathy and a lack of consensus by the
expert researchers and clinicians around diagnosis, and
inclusion criteria for tendinopathy research, one of the
ICON 2019 consensus papers reported standards for
reporting participant characteristics to provide greater
detail of who is included within research studies to facilitate clinical translation.18 Another ICON 2019 consensus
statement provided a list of nine core health domains
that should be considered in tendinopathy research:
(1) patient rating of the condition; (2) participation
in life activities; (3) pain on activity/loading; (4) function; (5) psychological factors; (6) physical function
capacity; (7) disability; (8) quality of life; and (9) pain
over a specified time.19 Furthermore, a number of other
domains identified within the ICON 2019 statement of
core health domains were considered of little importance
in monitoring19; however, some did feature within the
ICON 2019 consensus statement of reporting participant
characteristics and are important to consider when investigating the diagnosis and monitoring of tendinopathy in
clinical practice: (1) tendon structure; (2) palpation; and
(3) range of motion.18 These health domains represent
the first step in consensus on what outcome measures are
important to clinicians, patients and researchers.
The irony is that clinicians have it drilled into them
to be evidence based, but when it comes to assessment
tools for mid-portion Achilles tendinopathy the research
studies they read do not use uniform diagnostic criteria or
assessment tools, and the experts cannot reach consensus
on exactly what is needed to diagnose the condition.
Therefore, can we really expect clinicians to select the
most valid and reliable assessment tools?
To address the confusion within the research, the
Achilles Tendinopathy International Consensus Sub-
Group has worked to identify all assessments used within
clinical studies of Achilles tendinopathy and allocate
them under the ICON core health domain of ‘best fit’.14
2

This project involves further reviews and a Delphi study
to determine which outcome measures are most valid
and reliable and make recommendations regarding
which assessments best represent each health domain.
However, this body of work does not definitively indicate
what current practice ‘at the coalface’ is for clinicians
when diagnosing and monitoring Achilles tendinopathy.
Specifically, there is merit in knowing what assessments
clinicians use and what assessments clinicians consider
ideal practice when diagnosing and monitoring Achilles
tendinopathy. Further to this, if discrepancy exists
between what clinicians do and what they consider ideal
practice, it is vital we understand what the barriers to
ideal practice are so that strategies can be implemented
to address the barriers.
Objectives
The primary objective of this study was to explore the
barriers preventing clinicians from implementing what
they think is ideal practice as it relates to using tools to aid
diagnosis and monitor progress in mid-portion Achilles
tendinopathy. Our secondary objectives were to describe
the assessments (assigned to an outcome measure domain
they represent) employed by clinicians in their own practice to aid with (a) diagnosis and (b) monitoring progress
in Achilles tendinopathy and explore which outcome
measure domains clinicians believe to be the most and
least important when managing patients with Achilles
tendinopathy.
METHODS
We conducted a qualitative study using semistructured
to-
one interviews. This study has been reported
one-
using the Consolidated Criteria for Reporting Qualitative
Research20 to identify the descriptions and experiences
of clinicians who treat mid-portion Achilles tendinopathy
related to specific concepts of interest.
Concepts of interest
To address the objectives of our study, we developed
a series of interview questions that were presented to
clinicians (online supplemental appendix A). Each of
the 10 questions relate specifically to our concepts of
interest. Questions explored which assessments were
performed in a ‘real world’ setting as well as any additional assessments clinicians would use in an ideal
world to assist diagnosis and to monitor patient progress over time. Additionally, outcome measure domains
(informed from the ICON core health domains) that
the interviewed clinicians’ thought were the most/least
important were also explored. Finally, clinicians were
asked which outcome measure domains they believed
indicated meaningful progress for patients and what
barriers they perceived in implementing ideal practice
for assessment and monitoring of patients with mid-
portion Achilles tendinopathy.
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Patient and public involvement
This study did not involve patients; hence, they were not
involved. Clinicians (acting as the population of interest)
were invited to participate in this study.
Research team and reflexivity
Personal characteristics
Four members of the research teams conducted all
interviews (JD, WG, MCM and MT) with personal characteristics described in online supplemental appendix B.
Relationship with participants
All participants were clinicians, identified by the research
team through professional networks. To minimise relationship bias, we allocated interviewers (JD, WG, MCM or
MT) based on having no relationship with the participant.
There was no foreseeable bias within the characteristics
of the interviewers.
Study design
Methodology
We employed a qualitative descriptive study design to
capture the clinical assessments and outcome measure
domains participants deemed important when assessing
and monitoring mid-portion Achilles tendinopathy over
time.21 Qualitative descriptive methodology is suitable
in healthcare research as it helps to focus research questions directly on the experiences of participants rather
than through researcher interpretation or a theoretical
lens.22 Qualitative descriptive study designs are inherently
simple, yet flexible, and allow researchers to perform
descriptive research based on qualitative methodology.23
Furthermore, some of the key features of qualitative
descriptive research include semistructured interviews or
small focus groups, purposive sampling, descriptive statistics and thematic analysis24 making this research design
ideal when considering our objectives.
Participant selection
We used purposive sampling25 to recruit Australian
participants from four clinical subgroups: (1) junior
physiotherapists, (2) senior physiotherapists working in
private practice, (3) senior physiotherapists working in
elite sport, and (4) sport and exercise medicine doctors
(inclusion criteria for each group are listed within online
supplemental appendix C). Purposive sampling is a
non-probability sampling technique which selects participants who possess the maximum amount of information
about a particular topic.26 We sampled continuously until
thematic saturation21 27 was achieved (n=13), as determined by the principal investigator (MCM); however, we
would have continued to sample further participants had
saturation not been achieved.
We invited 28 participants into this study who were
contacted by email and provided the participant information sheet, consent form, interview script (online
supplemental appendix C) and instructions on how to
enrol into the study. Of these, 15 participants either
declined to be involved or failed to respond (five junior

physiotherapists, two senior physiotherapists working in
private practice, three senior physiotherapists working in
elite sport and five sport and exercise medicine doctors).
Overall, 13 participants (eight female, five male) from
across Australia (online supplemental appendix D)
consented to participate in this study. At the point of
data saturation, two junior physiotherapists, five senior
physiotherapists working in private practice, four senior
physiotherapists working within elite sports organisations and two sport and exercise medicine doctors were
enrolled.
Setting
All interviews were conducted between May 2020 and May
2021 using an online platform (Zoom Cloud Meetings28)
with only the participant and the interviewer present.
Data collection
The duration of interviews ranged from 20 to 55 min
and were audio recorded. We employed a cognitive
interviewing technique following the conclusion of
each of the first three interviews to ensure questions
were understandable and facilitated discussion that
addressed the concept topic. These participants were
asked (1) if there were any questions they did not understand and (2) whether they felt the questions addressed
the concept topics appropriately. Thereafter, we made
minor amendments to the interview schedule to better
explain the outcome measure domains with examples
being provided for participants on request. The principal
investigator (MCM) generated transcripts using Descript
V.20.1.429 and subsequently cross-checked them with the
audio recording. Final transcripts were not provided to
participants for member checking.
Analysis
Data analysis
A single researcher (MCM) coded all data using QSR
NVivo (V.12.6.1.970)30 under the guidance of a member
of the research team (CB) who has substantial experience with QSR NVivo for qualitative research analysis.
We sought significant statements that captured individual perspectives of participants. A template thematic
analysis approach was used whereby the coding structure
was guided by an initial skeleton code frame based on
the concept of interest, and subsequently built on during
the coding phase (coding structure presented in online
supplemental appendix E).31 The clinical assessments
mentioned by participants within script questions 1, 2, 6
and 7 were coded to one of the previously mentioned
outcome measure domains, which acted as our themes
(eg, the coding nodes within NVivo). The outcome
measure domains were used due to the absence of any
other relevant coding structures from existing literature,
and because it has been established the ICON health
domains are of interest to researchers, clinicians and
patients. Where an assessment did not fit within one of
the outcome measure domains it was included as ‘other’
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Figure 1 (A) Tree map representing the assessments clinicians perform in a ‘real world’ setting to assist diagnosis. (B) Tree
map representing the assessments performed by clinicians in a ‘real world’ setting to monitor progress, where a larger box
represents a larger response. Outcome measure domains that were not assessed by clinicians are not included within the
figure.

to ensure that results were not biased by only presenting
the domains identified within the ICON statement. For
all questions related to participants selecting the most/
least important outcome measure domains for assessment of monitoring, all responses were coded as the
outcome measure domain directly indicated by the clinician. Themes were derived from the data related to the
barriers for the implementation of ideal clinical assessment and monitoring.
Reporting
Results of the template thematic analysis are presented
as figures or tables inclusive of the key themes and separated into the key topics of interest. Quotations were
included as supporting statements to the key themes
outlined within the results.
RESULTS
Assessments used to assist diagnosis
Assessments performed by clinicians in a ‘real world’ setting
Clinicians identified assessments representing four key
outcome measure domains they used most to assist diagnosis: function (85%, 11/13), pain on loading (92%,
12/13), pain over a specified time frame (77%, 10/13)
and palpation (85%, 11/13) (figure 1A). Footwear was
mentioned by 46% of clinicians as being assessed in
routine practice and was coded under a separate outcome
measure domain of ‘Other’.
Additional assessments clinicians would perform in an ‘ideal
world’ setting
Clinicians identified three outcome measure domains
of interest for assessments they would use in an ideal
world: physical function capacity (54%, 7/13), disability
(31%, 4/13) and tendon structure (31%, 4/13) (online
supplemental appendix F). One clinician reported
they would ideally assess calf circumference, and this
4

was coded under a separate outcome measure domain
‘Other’. Clinicians felt in an ‘ideal’ world assessing physical function capacity using a force plate (eg, ground
reaction force for jumping and landing), disability using
reported outcome measures (eg, Lower Extremity
self-
Function Scale) or tendon structure using imaging (eg,
ultrasound) would be valuable to assist diagnosis.
Outcome measure domains viewed as important by clinicians
Clinicians identified assessments belonging to two
outcome measure domains as being most important for
diagnosing Achilles tendinopathy: pain on loading (92%,
12/13) and pain over a specified time frame (69%, 9/13)
(figure 2A). Clinicians identified assessments belonging
to one outcome measure domain as being least important
for diagnosing Achilles tendinopathy: tendon structure
(62%, 8/13)(figure 2A).
While 85% of clinicians routinely assessed palpation
and 46% routinely assessed range of motion, these
were not identified as important outcome measure
domains for diagnosing tendinopathy. Only 31% of clinicians rated palpation in their most important outcome
measure domains and no clinicians rated range of
motion within their most important outcome measure
domains (table 1). Themes representing clinically
performed assessments used by clinicians for diagnosis
yet not considering important outcome measure domains
included palpation, which clinicians felt was expected by
the patient, and range of motion which is assessed but
not potentially useful for diagnosis.
Assessments used to monitor progress over time
Assessments performed by clinicians in a ‘real world’ setting
Most clinicians identified assessments belonging to four
outcome measure domains as being used to monitor
progress: disability (62%, 8/13), pain on loading (69%,
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Figure 2 (A) Outcome measure domains clinicians view as important to assist diagnosis. (B) Outcome measure domains
regarded as important by clinicians to monitor progress.

9/13), pain over a specified time frame (85%, 11/13)
and physical function capacity (92%, 12/13) (figure 1B).
Additional assessments performed by clinicians in an ‘ideal world’
setting
Clinicians identified assessments belonging to four
outcome measure domains they would assess in an ideal
world: tendon structure (54%, 7/13), disability (15%,
2/13), physical function capacity (15%, 2/13) and function (8%, 1/13) (online supplemental appendix G).
Clinicians felt in an ‘ideal’ world monitoring tendon
structure using imaging (eg, ultrasound tissue characterisation), monitoring disability (eg, administering
a Victorian Institute of Sport Assessment-
Achilles) or
monitoring ground reaction force (eg, through use of a
force plate) would be valuable.
Outcome measure domains regarded as important by clinicians
Clinicians identified assessments belonging to three
outcome measure domains as being the most important
for monitoring progress: pain on loading (69%, 9/13),

patient rating of the condition (62%, 8/13) and physical
function capacity (54%, 7/13) (figure 2B). Clinicians
identified assessments belonging to three outcome
measure domains as least important for monitoring progress: tendon structure (77%, 10/13), palpation (54%,
7/13) and range of motion (38%, 5/13) (figure 2B).
Most clinicians (92%, 12/13) routinely monitor
physical function capacity and 85% (11/13) routinely
monitor pain over a specified time frame. However, only
54% (7/13) and 31% (4/13) of clinicians felt physical
function capacity and pain over a specified time frame,
respectively, were among the most important core
outcome measure domains (table 2). Alternatively, no
clinicians (0%) routinely assessed psychological factors,
yet 15% (2/13) reported that psychological factors were
one of the most important outcome measure domains
(table 2). Participants recognised the importance of
addressing the psychological factors among patients in
monitoring progress, yet no participating clinicians actually did this.

Table 1 Assessments clinicians routinely use within clinical practice when diagnosing Achilles tendinopathy, yet do not
consider the underlying core outcome measure domain as important

Key theme
Palpation*

Range of
motion*

Description of health
domain from ICON
201919
Exemplar quote
‘Manual pressure
elicited/evoked pain
over the tendon (eg,
VAS, NRS).’19
‘Range of motion
(eg, goniometer,
inclinometer).’19

‘And palpation is, you know… I’d rather go by function than anything else. So I
probably…do it more as part of your examination, as part of the show, really.’ (Participant
3)
‘I would suggest range of movement is not so important in diagnosis, even though I did
mention before that I would take that into consideration, I don’t think it’s really up there in
terms of being of utmost importance for diagnosis.’ (Participant 7)

*Palpation and range of motion were not listed as a core health domain of tendinopathy in the ICON statement.
NRS, Numerical Rating Scale; VAS, Visual Analogue Scale.

Murphy MC, et al. BMJ Open Sp Ex Med 2022;8:e001355. doi:10.1136/bmjsem-2022-001355

5

BMJ Open Sport Exerc Med: first published as 10.1136/bmjsem-2022-001355 on 21 June 2022. Downloaded from http://bmjopensem.bmj.com/ on September 18, 2022 at Edith Cowan
University. Protected by copyright.

Open access

Table 2 Outcome measure domains regarded as important by clinicians to monitor progress
Key theme

Description of health domain from ICON
201919
Exemplar quote

‘Psychological factors, again, understanding that, we’re not
‘Psychology (eg, pain self-efficacy, pain
catastrophisation, kinesiophobia, anxiety or just treating a tendon, we’re treating the whole patient. And
if there are psychological factors that impact our ability to
depression scales).’19
treat that patient and that tendon, then we need to address
those. Otherwise, we're not necessarily going to get there.’
(Participant 13)
‘I guess when I’m thinking about if someone’s not
progressing or if they’re not progressing, maybe the
way that there might be, social or psychological factors.’
(Participant 2)
‘Physical function capacity too, because it’s easy to
Physical function
‘Quantitative measures of physical tasks
measure. And because I think it’s really correlated. If we can
capacity
performed in clinic (eg, number of hops,
get some improved kind of strength through the complex,
timed stair walk, number of single limb
we tend to be able to see that people can tolerate loading a
squats, including dynamometry (strength)
bit more.’ (Participant 7)
and wearable technology).’19
‘Probably the pain response to load and whether they’re
Pain over a
‘Participant reported pain intensity over a
specified time frame period of time (morning, night, 24 hours, a having any associated calf tightness… what does that
person look like? Post-game and, do they have a pain 24
week; eg, VAS, NRS).’19
hours later, 48 hours later, 72 hours later?’ (Participant 5)
Psychological
factors

NRS, Numerical Rating Scale; VAS, Visual Analogue Scale.

Defining meaningful progress
Clinicians found it difficult to articulate meaningful progress given that it is outcome measure specific. However,
two key themes emerged: (1) clinicians are happy with
progress provided they observe a positive trajectory
(regardless of the magnitude of change), and (2) clinicians tend to have a finish goal they expect a patient to
achieve (table 3).

practice. The ICON 2019 consensus statement progressed
the field by developing core health domains on which
to map tendinopathy outcome measures.19 Building on
this work, this is the first study to qualitatively explore the
perceptions and experiences of clinicians in relation to
assessment and monitoring of patients with mid-portion
Achilles tendinopathy, with assessments mapped to the
ICON 2019 core health domains.

Barriers to implementing optimal assessment
Clinicians identified several barriers to performing
what they would consider optimal monitoring of their
patients with Achilles tendinopathy (table 4). The four
main themes were: ‘Financial constraints’ (9/13), ‘Time
constraints’ (8/13), ‘Access to Equipment’ (4/13)
and ‘Patients Symptom Severity’ (3/12), with eight
other minor themes emerging. In terms of ‘Financial
constraints’, clinicians were aware of the costs to patients
in terms of deciding which course of treatment to recommend. Participants reported ‘Time constraints’ as being
an issue to monitoring patients with the focus being
on management as opposed to reassessment. Participants recognised that ‘Access to Equipment’ can be a
problem in a shared clinical environment. Participants
also reported ‘Patient Symptom Severity’ was a barrier to
monitoring as they did not want to perform assessments
likely to aggravate patient symptoms.

The use of clinical assessments to diagnose Achilles
tendinopathy
Clinicians commonly use assessments that measure function, pain on loading, pain over a specified time frame
and palpation to assist diagnosis. Despite this, in our
study, clinicians considered only pain on loading and
pain over a specified time frame as being important
outcome measure domains. Furthermore, we demonstrated that clinicians use, and consider relevant, some of
the health domains classified by the ICON 2019 as ‘non-
core health domains’. Specifically, clinicians reported
routinely palpating the tendon and measuring range
of motion as part of the diagnostic process for mid-
portion Achilles tendinopathy. While palpation may be
considered as useful for ruling out a diagnosis of Achilles
tendinopathy, its value in prognosis is poor. Mechanical
sensitivity of the tendon will also vary due to a number
of different centrally mediated processes32 and should be
interpreted with caution.
Of interest, while clinicians commonly assessed these
outcome measure domains, they were not rated by clinicians as being essential for reaching a diagnosis. Our
findings echo those in other conditions, such as low back
pain and knee osteoarthritis, where a disparity exists

DISCUSSION
A plethora of different assessment tools exist to assist in
the diagnosis and monitoring of progress for mid-portion
Achilles tendinopathy. Despite this, no consensus exists
on which of these tools are meaningful for use in clinical
6
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Table 3 Defining meaningful progress
Key theme

Description of theme

Clinicians are happy with
progress provided they
observe a positive trajectory
(regardless of the magnitude
of change).

Monitoring meaningful change in patients is
hard, and no one number is ever going to be
meaningful for every patient. Clinicians instead
tend to look for a positive trajectory and judge,
based on their own clinical experience, whether
progress is satisfactory or not.

Clinicians tend to have a
finish goal they expect a
patient to achieve.

Exemplar quote

‘I think that’s a really open, difficult thing to
answer, but you don’t want to also spend
six weeks doing a program and then having
come back with a one point change on your
VISA.’ (Participant 8)
‘It would be more like a trend, I guess there’s
no specific set number, but like a positive
trend, you know, towards the higher numbers.’
(Participant 10)
‘Wanting to see a two to three point drop…
but again, it really depends if they are only a
three out of 10 versus if they're at an eight
out of 10, it’s going to be more based on a
percentage.’ (Participant 7)
While clinicians may not have clear increments ‘You would certainly not want to be, in my
of improvement, they expect to see over
opinion, progressing that run distance until
time they often have a goal they expect
the calf rises are probably close to 25.’
(Participant 11)
to see achieved for the relevant outcome
measure before allowing a patient to progress ‘For the calf raise then, I mean, really depends
on his level of fitness beforehand, but using,
rehabilitation.
say the other side as an example, I’d be then
thinking, okay, what we’d want to be getting at
least to there, but probably a bit higher. And
I’d be looking at 20–25 I think, for a running
athlete.’ (Participant 7)

VISA, Victorian Institute of Sport Assessment.

between what is recommended and what is performed
clinically.33 34 These findings highlight the heterogeneity
of assessments used in clinical practice as diagnostic
criteria for Achilles tendinopathy. This is an important
finding as it means that there is likely to be substantial
heterogeneity of clinical phenotypes within an Achilles
tendinopathy population, even when diagnosed by
healthcare providers.
The use of clinical assessments to monitor Achilles
tendinopathy
Clinicians commonly measure disability, pain on loading,
pain over a specified time frame and physical function
capacity to monitor progress over time. When comparing
the similarity of what assessments are being performed
and what outcome measure domains clinicians thought
were important, there was much more similarity within
assessments used for monitoring, as opposed to diagnosis. For example, both pain on loading and physical
function capacity were assessed in clinical practice and
viewed as important by clinicians. However, we identified
a disparity between some outcome measure domains
that clinicians monitor to assess progress over time and
those that clinicians think are the most important. For
instance, some clinicians reported psychological factors
as an important outcome measure domain yet they do not
assess psychological factors within their clinical practice.
It was also surprising to see very few clinicians mentioned
that they would assess and monitor psychosocial factors

throughout rehabilitation, in stark contrast to what is
considered important for other musculoskeletal conditions.35 36 However, these findings reflect what has been
seen in other musculoskeletal conditions with psychosocial screening tools not being routinely used.37 This may
be explained by the several barriers clinicians identified
that exist to implementing ideal practice.
Barriers to performing ‘ideal’ practice
Two clinicians reported they would not include additional
assessments to assist with diagnosis and three clinicians
reported they would not include additional assessments
to assist with monitoring within an ‘ideal’ world scenario.
This suggests that clinicians felt doing more would add
value. However, there is no current evidence that suggests
performing more assessments provides additional value
or improves patient outcomes in mid-portion Achilles
tendinopathy. In fact, the concept of ‘over-testing’ might
actually be associated with harm.38
The main barriers to implementing what clinicians
felt was ideal practice were ‘financial constraints’, ‘time
constraints’, ‘access to equipment’ and ‘patients symptom
severity’. These barriers reflect those identified in other
chronic musculoskeletal complaints.37 39 Exploring these
barriers in terms of their potential for modification,
and thus the potential to optimise practice is warranted.
Certain barriers could be removed at the individual level,
for instance, by training clinicians to efficiently, effectively
and routinely use patient-reported outcome measures.
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Table 4 Barriers to implementing optimal assessment for assessment and monitoring of patients with mid-portion Achilles
tendinopathy
Key theme

Definition of key theme

Exemplar quote

Financial
constraints

Clinicians are conscious of the financial
burden their services place on patients and
opt for the outcome measure that would
give them the ideal information to inform
management strategies.

Time constraints

Clinicians reported that having sufficient
time within consultations prevents them
from assessing everything they would
typically like to within consultations.

‘Costs can sometimes be an issue. So that’s why they
might not engage with physio because again, it’s more cost.
And that’s why I always say to them, look, I could do some
imaging. I could spend some money on imaging or an MRI or
something like that, but I don't want to spend that on you or
an injection.’ (Participant 3)
‘Patient cost is definitely part of it.’ (Participant 8)
‘Can they afford to see me every two weeks for follow up?’
(Participant 2)
‘Time that they’re allowed to spend at the club. And the time
allocated to pre-training screening is actually, pretty limited.’
(Participant 5)
‘I just didn’t have time to do all of them [outcome measures]
every single time.’ (Participant 4)
‘Time again [as a barrier] for the more elaborate things like,
you know, that one RM lift-off test or whether it’s, endurance
tests.’ (Participant 8)

Access to
equipment

Clinicians reported that access to
equipment could be an issue. They may
want to do certain assessments but
either do not have the equipment or the
equipment is being used for another
purpose during their patients’ consult.

‘I do like to get them on the treadmill or get them out into that
space as we have one, but sometimes there’s gym classes
and things, we can't access it.’ (Participant 2)
‘For me at work in private practice, I don’t have capacity to
look at that. So, if it was part of a program for a patient, they
were doing it in Smith machine. For example, at the gym, I’d
get them to report back to me.’ (Participant 9)

Patient symptom
severity

Clinicians were conscious of performing
too many assessments, which may provide
valuable information, at the cost of flaring
up the symptoms of a patient with an
irritable condition.

‘The patient’s symptoms are the perfect barrier to do a
strength assessment.’ (Participant 4)
‘I think part of this comes down to how irritable or not it
[Achilles tendon] is.’ (Participant 11)
‘Does it [Physical examination] overload the patient?’
(Participant 8)

Access to sports Clinicians reported that in some situations
medicine doctors access to sports medicine doctors would
be valuable but it is often challenging
logistically.

‘I think that’s always the barrier. I mean, when we talk about
these kind of these amazing sports clubs… they can actually
go and do the blood tests, they're on site.’ (Participant 1)

Decreased
monitoring once
improvement was
clear

‘Athletes… they can tend to slip through the cracks once they
start going well, you might not monitor their loads as closely.’
(Participant 5)

It was reported that it can be easy to
decrease the amount of monitoring when
you are getting clear improvements with a
patient.

Engagement with It was reported that when someone has
the management failed rehabilitation, or is not progressing
plan
at the rate, they may want that having the
patient re-engage with healthcare providers
can be a challenge.

‘So for me, it’s then convincing them to go back to their
physio to progress this. Or if they’re not comfortable with
that, then finding them someone else who can, who’s good
at giving a tendon reloading program. I think that’s one of the
biggest barriers I find.’ (Participant 3)

Good
communication
between
healthcare
providers

‘To have that dialogue with the patient and then try and have
that dialogue with the physiotherapist, by sending them a
letter outlining what I think is going on and hopefully that they
give me correspondence back that it keeps me in the loop.’
(Participant 13)

Knowledge of
what to assess
and monitor

Communication was reported to be an
issue and sometimes a clinician within
the multidisciplinary team might be
performing monitoring; however, with
poor communication channels between
healthcare providers not everyone is aware
of this.
Clinicians’ knowledge was reported to
be a barrier as inexperienced clinicians
are not sure of everything they should be
assessing.

‘I don’t really know what I don’t know yet. And, I’m still
learning my way through lots of things.’ (Participant 2)

Continued
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Table 4 Continued
Key theme

Definition of key theme

Motivation to
prepare self-
reported outcome
measures

The burden of having to prepare self-
‘In brutal honesty, motivation and organization. So if I’m busy,
reported measures in advance, such as the and I don’t get printing off each day, I might not do a VISA,
VISA, was reported. This can lead clinicians and you can call that laziness.’ (Participant 12)
to not providing these assessments to
patients.

Patient
understanding

Clinicians feel like patients do not always
understand self-reported outcome
measures and they can lack confidence in
the findings of these tools.
While patients may have the ideal
intentions to monitor things like running
distance or daily symptoms, sometimes
they will forget and therefore this cannot be
provided to the clinician.

Patient
compliance to
monitoring

Exemplar quote

‘Sometimes when you get to the functional questions at the
end, it just gets the patient gets a bit confused. I think. And
I’m not, I’m not sure that it’s, look, it’s obviously been… tested
and validated, so it’s a good one, but yeah.’ (Participant 3)
‘Some things in practice that I say people like, they just forget
to do it.’ (Participant 10)

RM, Repitition Maximum; VISA, Victorian Institute of Sport Assessment.

Likewise, other barriers could be removed at the institutional and cultural levels by optimising relationships
and communication between different subgroups of
clinicians. In contrast, we recognise barriers that exist
which may not be modifiable. For example, clinicians
concern that a patient’s financial constraints are difficult
to overcome, although this does assume the clinician
has established a thorough understanding of personal
resources. This may not necessarily be the case and was
not reported by physiotherapists working within elite
sport where cost is not a barrier. While several strategies
exist to remove this barrier, one solution is to avoid costly
assessment protocols not supported by the evidence,
such as imaging,40 and given the potential for iatrogenic
effects related to overtesting this barrier might actually
be useful. However, it should be acknowledged that some
factors (such as geographical or cultural factors) influence whether imaging is a financial burden with many
countries globally not having out-of-pocket expenses for
patient imaging. These resources could then be redirected to fund ideal practice management, which could
be mediated through clinician education. Likewise, the
development of online, freely available resources for
patients might assist in reducing the number of required
consultations.41 The provision of better educational
resources (either isolated or in conjunction with exercise
rehabilitation) for patients may also help decrease the
time burden clinicians identified as being a key barrier
and are being trialled in other chronic musculoskeletal
complaints such as chronic lower back pain.41 42
Access to equipment is difficult to overcome but the use
of reliable measures of physical function capacity which
do not require equipment should be encouraged (eg,
single leg heel raise) as these may provide valuable information and negate the need for equipment.43 However,
patient symptoms can significantly improve in the
absence of any changes in calf endurance, as measured
by a single leg heel raise,44 so the clinicians must be clear

on why they are assessing physical function capacity.
Patient symptom severity will always be a barrier in irritable presentations. However, assessments providing a
measure of physical function capacity without increasing
pain should be considered. The reality that outcome
measure domain focus shifts during the clinical journey
assists with this issue, with the initial focus being on pain-
related outcome measure domains, then progressing to
more disability and functional outcome measure domains
as the patients’ clinical status improves.45
Limitations
We used one-on-one interviews as they can generate a
range of themes on a per-person basis and provide very
detailed transcripts for analysis.46 One-on-one interviews
were used to ensure participants were comfortable with
discussing their own barriers to ideal practice, specifically
related to what they do not do as well as they could. For
this reason, we decided against conducting focus groups
as we believed participants would feel more comfortable
in a one-to-one setting rather than in a focus group setting
containing respected peers.27 As such, interviews are ideal
practice for exploring the descriptions of the experiences
and perceptions held by individuals and while they are
associated with small sample sizes compared with larger
quantitative studies they are rich in data and appropriate
to answer the questions posed in this study.27
The ICON 2019 consensus statement of core health
domains of tendinopathy is only recently published so
it would be unlikely any large-scale change in clinical
practice would have occurred. Hence, this study cannot
assess the impact of the consensus statement, and only
depicts what is currently being performed in clinical
practice. Given the applicability of using the core health
domains as nodes to code the data, we performed this for
both diagnostic and monitoring measures mentioned by
participants. However, we recognise diagnosis was never
the purpose of the core health domains paper.
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We interviewed a heterogeneous population of clinicians across disciplines and across career stages to capture
breadth of perspective, which results in some limitations.
First, our final sample only included one sport and exercise
medicine physician and one sport and exercise medicine
registrar. Therefore, sport and exercise medicine may
be under-
represented within our sample. Second, we
did not include other healthcare providers who manage
mid-portion Achilles tendinopathy (eg, podiatrists, exercise physiologists or general practitioners). Although
thematic saturation was reached within the interviews
conducted, the results are not intended to be representative of the broader population and cannot be assumed
to represent other provider groups. Nonetheless, the
findings were insightful, and generalisability could be
rectified by future larger studies (eg, survey). Such a
study could be developed based on the themes identified
within this study and administered to large numbers of
clinicians. This would provide more accurate estimates
on the disparities between current clinical practice and
‘ideal’ practice, and what the barriers to ideal practice
are. Furthermore, a survey could enable analysis of how
demographic features such as specialty and experience
might impact these perspectives.

School of Medical and Health Sciences, Edith Cowan University, Joondalup,
Western Australia, Australia
5
La Trobe Sport and Exercise Medicine Research Centre, La Trobe University,
Melbourne, Victoria, Australia
6
School of Public Health and Preventative Medicine, Monash University, Clayton,
Victoria, Australia
7
School of Physiotherapy and Exercise Science, Curtin University, Perth, Western
Australia, Australia

CONCLUSION
No consensus exists that helps clinicians decide which
clinical assessment tools assist in the diagnosis or monitoring over time of patients with Achilles tendinopathy.
Assessments related to function, pain on loading, pain
over a specified time frame and palpation are commonly
used to assist diagnosis. Assessments related to disability,
pain on loading, pain over a specified time frame and
physical function capacity are used to monitor progress
over time. Furthermore, pain on loading and pain over a
specified time frame were considered the most important
outcome measure domains for assisting diagnosis whereas
pain on loading, patient rating of the condition and physical function capacity were the most important outcome
measure domains for monitoring progress. Finally, four
main themes were perceived as barriers to implementing
ideal practice of assessment and monitoring in people
with Achilles tendinopathy: financial constraints, time
constraints, access to equipment and patient symptom
severity.
Recommendations for clinicians on what assessments
should be used in clinical practice should consider the
barriers to optimal clinical assessment. Considering these
barriers may assist compliance with recommendations in
providing optimal clinical care for patients with Achilles
tendinopathy.
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